Ucb

UCB is a global biopharmaceutical company specializing in neurology and immunology. They generate revenue by developing and marketing innovative medicines and solutions for severe diseases such as epilepsy, Parkinson's disease, and rheumatoid arthritis. Founded in 1928 in Belgium, UCB has a rich history of scientific breakthroughs and strategic acquisitions, including the purchase of Schwarz Pharma in 2006. The company is committed to improving patient outcomes through cutting-edge research and a patient-centric approach.

Recent Posts by Ucb

1-20 of 940